Boehringer Ingelheim International GmbH
Cancer takes. Takes away loved ones, time and untapped potential. At Boehringer Ingelheim we are taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. We are advancing cancer cell directed agents, immune oncology therapies and combination approaches, primarily in lung and gastrointestinal cancers, to complement our existing portfolio. Our goal is delivering breakthrough, first-in-class treatments that can help win the fight against cancer.